Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP219991.RAo8N9H3fN-N6XA-JgrH2kKfvZ1u0DBU1ptXU_N8Pylu0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP219991.RAo8N9H3fN-N6XA-JgrH2kKfvZ1u0DBU1ptXU_N8Pylu0130_assertion type Assertion NP219991.RAo8N9H3fN-N6XA-JgrH2kKfvZ1u0DBU1ptXU_N8Pylu0130_head.
- NP219991.RAo8N9H3fN-N6XA-JgrH2kKfvZ1u0DBU1ptXU_N8Pylu0130_assertion description "[In this study, resistant sublines of the histiocytic lymphoma cell line U-937 GTB and the myeloma line RPMI 8226 were developed by culturing under gradually increasing concentrations of CHS 828 until reaching 25 times the parental line EC50s.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP219991.RAo8N9H3fN-N6XA-JgrH2kKfvZ1u0DBU1ptXU_N8Pylu0130_provenance.
- NP219991.RAo8N9H3fN-N6XA-JgrH2kKfvZ1u0DBU1ptXU_N8Pylu0130_assertion evidence source_evidence_literature NP219991.RAo8N9H3fN-N6XA-JgrH2kKfvZ1u0DBU1ptXU_N8Pylu0130_provenance.
- NP219991.RAo8N9H3fN-N6XA-JgrH2kKfvZ1u0DBU1ptXU_N8Pylu0130_assertion SIO_000772 15090743 NP219991.RAo8N9H3fN-N6XA-JgrH2kKfvZ1u0DBU1ptXU_N8Pylu0130_provenance.
- NP219991.RAo8N9H3fN-N6XA-JgrH2kKfvZ1u0DBU1ptXU_N8Pylu0130_assertion wasDerivedFrom befree-20150227 NP219991.RAo8N9H3fN-N6XA-JgrH2kKfvZ1u0DBU1ptXU_N8Pylu0130_provenance.
- NP219991.RAo8N9H3fN-N6XA-JgrH2kKfvZ1u0DBU1ptXU_N8Pylu0130_assertion wasGeneratedBy ECO_0000203 NP219991.RAo8N9H3fN-N6XA-JgrH2kKfvZ1u0DBU1ptXU_N8Pylu0130_provenance.